サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1392831

血漿分画の世界市場レポート 2024年

Plasma Fractionation Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血漿分画の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

血漿分画の市場規模は近年力強く成長しています。2023年の289億5,000万米ドルから2024年には317億8,000万米ドルに、CAGR9.8％で拡大します。過去の期間に観察された成長は、血友病と免疫不全障害の有病率の増加、高齢化人口の増加、免疫グロブリンの需要の増加、血漿収集センターの拡大、外科手術の件数の増加など、いくつかの要因に起因しています。

血友病の有病率の増加は、血漿分画市場の重要な促進要因になると考えられます。血友病は血液凝固に影響を及ぼすまれな遺伝性疾患で、出血症状の長期化につながります。血漿分画は、血液凝固を促進するために血友病患者に投与される凝固因子の生産に不可欠です。世界血友病連盟によると、世界で毎年約20,000人の血友病患者が誕生しており、そのうち7,000人は重症例です。現在の世界の男性人口39億人のうち、血友病患者は81万8928人と推定されます。従って、血友病の有病率の増加は、血漿分画市場を促進すると予想されます。

2023年の血漿分画市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域と予想されます。

目次

第1章 エグゼクティブサマリー

第2章 血漿分画市場の特徴

第3章 血漿分画市場の動向と戦略

第4章 血漿分別市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の血漿分画市場の規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033F

第6章 血漿分画市場セグメンテーション

  • 世界の血漿分画市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 免疫グロブリン
  • 凝固因子
  • アルブミン
  • プロテアーゼ阻害剤
  • 世界の血漿分画市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 免疫学
  • 血液学
  • 神経学
  • 救命救急診療
  • 血液腫瘍学
  • リウマチ学
  • 世界の血漿分画市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 病院・診療所
  • 臨床研究機関
  • 学術機関

第7章 血漿分画市場の地域別・国別分析

  • 世界の血漿分画市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
  • 世界の血漿分画市場、国別、実績および予測、2018-2023、2023-2028F、2033F

第8章 アジア太平洋の血漿分画市場

  • 概要
  • 地域情報、COVID-19症の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国の血漿分画市場

第10章 インドの血漿分画市場

第11章 日本の血漿分画市場

第12章 オーストラリアの血漿分画市場

第13章 インドネシアの血漿分画市場

第14章 韓国の血漿分画市場

第15章 西欧の血漿分画市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国の血漿分画市場

第17章 ドイツの血漿分画市場

第18章 フランスの血漿分画市場

第19章 イタリアの血漿分画市場

第20章 スペインの血漿分画市場

第21章 東欧の血漿分画市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアの血漿分画市場

第23章 北米の血漿分画市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国の血漿分画市場

第25章 カナダの血漿分画市場

第26章 南米の血漿分画市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルの血漿分画市場

第28章 中東の血漿分画市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカの血漿分画市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 血漿分画市場の競合情勢と企業プロファイル

  • 血漿分画市場の競合情勢
  • 血漿分画市場の企業プロファイル
    • Baxter International Inc.
    • Bio Products Laboratory Limited
    • Biotest AG
    • CSL Limited
    • Grifols S. A

第31章 世界の血漿分画市場の競合ベンチマーキング

第32章 世界の血漿分画市場の競合ダッシュボード

第33章 血漿分画市場における主要な合併と買収

第34章 血漿分画市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10519

“Plasma Fractionation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plasma fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma fractionation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The plasma fractionation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Immunoglobulins; Coagulation Factors; Albumin; Protease Inhibitors
  • 2) By Application: Immunology; Hematology; Neurology; Critical Care; Hemato-Oncology; Rheumatology
  • 3) By End User: Hospitals and Clinics; Clinical Research Laboratories; Academic Institutes
  • Companies Mentioned: Baxter International Inc.; Bio Products Laboratory Limited; Biotest AG; CSL Limited; Grifols S. A
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Plasma fractionation is the process of integrating manufacturing procedures to sequentially isolate crude fractions, which are then further refined into specific medicinal products.

The primary products in the plasma fractionation market include immunoglobulins, coagulation factors, albumin, and protease inhibitors. Immunoglobulins find application in treating a wide range of disorders, encompassing primary and secondary immune deficiencies, autoimmune diseases, and inflammatory conditions. Immunoglobulins (Ig) and antibodies, glycoproteins produced by plasma cells, play a crucial role in the immune system's recognition and neutralization of foreign objects such as pathogenic bacteria and viruses. These products have various applications in immunology, hematology, neurology, critical care, hemato-oncology, and rheumatology, with end users spanning hospitals and clinics, clinical research laboratories, and academic institutes.

The plasma fractionation market research report is one of a series of new reports from The Business Research Company that provides plasma fractionation market statistics, including plasma fractionation industry global market size, regional shares, competitors with an plasma fractionation market share, detailed plasma fractionation market segments, market trends and opportunities, and any further data you may need to thrive in the plasma fractionation industry. This plasma fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma fractionation market size has grown strongly in recent years. It will grow from $28. 95 billion in 2023 to $31. 78 billion in 2024 at a compound annual growth rate (CAGR) of 9. 8%. The growth observed in the historical period can be attributed to several factors, including the increasing prevalence of hemophilia and immunodeficiency disorders, a rising aging population, a growing demand for immunoglobulins, the expansion of plasma collection centers, and an increase in the number of surgical procedures.

The plasma fractionation market size is expected to see rapid growth in the next few years. It will grow to $46. 72 billion in 2028 at a compound annual growth rate (CAGR) of 10. 1%. The anticipated growth in the forecast period can be attributed to several factors, including the rise in global healthcare expenditure, the increasing applications of plasma-derived medicinal products, a growing investment in research and development, the demand for plasma in the treatment of neurological disorders, and the expansion of plasma fractionation facilities. Key trends expected during this period include the development of new fractionation technologies, a shift towards albumin and immunoglobulin therapies, a rising demand for specialty plasma products, a focus on pathogen inactivation technologies, and strategic collaborations and partnerships in the plasma industry.

The anticipated increase in the number of chronic diseases is set to drive the growth of the plasma fractionation market. Chronic diseases, lasting one year or more and requiring ongoing medical attention, include conditions like heart disease, cancer, and diabetes. The treatment of chronic disease patients through plasma products not only reduces morbidity but also enhances the quality of life and proves to be cost-effective. A report by the National Library of Medicine projects a 99. 5% rise in individuals aged 50 years and older with one or more chronic illnesses by 2050, reaching 142. 66 million, up from 71. 522 million in 2020 in the United States. The surge in chronic disease cases across all age groups is expected to fuel the growth of the plasma fractionation market.

The increasing prevalence of hemophilia is poised to be a significant driver for the plasma fractionation market. Hemophilia, a rare genetic disorder affecting blood clotting, leads to prolonged bleeding episodes. Plasma fractionation is vital for producing clotting factors administered to individuals with hemophilia to facilitate blood coagulation. According to the World Federation of Hemophilia, approximately 20,000 people with hemophilia are born globally each year, with 7,000 having severe cases. In the current global male population of 3. 9 billion, there are an estimated 818,928 hemophilia patients. Thus, the growing prevalence of hemophilia is expected to propel the plasma fractionation market.

A key trend gaining traction in the plasma fractionation market is technological advancements. Major companies in the market are introducing innovative technologies, such as HYCON, featuring self-cleaning and fully automatic separators, to maintain their market position. In June 2021, the Germany-based company GAE launched HYCON, a fully automatic separator facilitating one-touch production for the separation of blood plasma and plasma proteins in clean room applications. The self-cleaning and fully automatic separator contribute to improved hygienic conditions, prevention of cross-contamination, and enhanced batch safety.

Strategic investments in expanding manufacturing capabilities for plasma-derived therapies (PDTs) are a focus for major players in the industry. This involves allocating resources to develop and enhance facilities and processes for the production of specialized therapies derived from blood plasma. In April 2023, Takeda Pharmaceutical, a Japan-based biopharmaceutical company, invested ¥100 billion (approximately $755. 8 million) to construct a state-of-the-art plasma-derived therapy manufacturing facility in Osaka. With a commitment to environmental sustainability, Takeda aims to achieve net-zero greenhouse gas emissions in its operations by 2035.

In April 2022, Grifols S. A., a Spain-based pharmaceutical and chemical product manufacturing company, completed the acquisition of Biotest AG for $317. 03 million (EUR 318 million). Through this strategic move, Grifols aims to enhance the availability of plasma medicines, expand its product line, and strengthen its position as the largest private European network of plasma facilities with 87 locations. The acquisition is expected to drive revenue growth, profitability expansion, and accelerate the advancement of research and development projects.

Major companies operating in the in the plasma fractionation market report are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, ProMetic Life Sciences Inc., Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Shire PLC, Takeda Pharmaceutical Company, Terumo BCT, Bioverativ Inc., China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Grifols International S. A., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

North America was the largest region in the plasma fractionation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the plasma fractionation market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The plasma fractionation market includes revenues earned by entities by combining manufacturing steps to isolate, in a sequential and integrated manner. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Plasma Fractionation Market Characteristics

3. Plasma Fractionation Market Trends And Strategies

4. Plasma Fractionation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Plasma Fractionation Market Size and Growth

  • 5.1. Global Plasma Fractionation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Plasma Fractionation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Plasma Fractionation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Plasma Fractionation Market Segmentation

  • 6.1. Global Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunoglobulins
  • Coagulation Factors
  • Albumin
  • Protease Inhibitors
  • 6.2. Global Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunology
  • Hematology
  • Neurology
  • Critical Care
  • Hemato-Oncology
  • Rheumatology
  • 6.3. Global Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

7. Plasma Fractionation Market Regional And Country Analysis

  • 7.1. Global Plasma Fractionation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Plasma Fractionation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Plasma Fractionation Market

  • 8.1. Asia-Pacific Plasma Fractionation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Plasma Fractionation Market

  • 9.1. China Plasma Fractionation Market Overview
  • 9.2. China Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Plasma Fractionation Market

  • 10.1. India Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Plasma Fractionation Market

  • 11.1. Japan Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Plasma Fractionation Market

  • 12.1. Australia Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Plasma Fractionation Market

  • 13.1. Indonesia Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Plasma Fractionation Market

  • 14.1. South Korea Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Plasma Fractionation Market

  • 15.1. Western Europe Plasma Fractionation Market Overview
  • 15.2. Western Europe Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Plasma Fractionation Market

  • 16.1. UK Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Plasma Fractionation Market

  • 17.1. Germany Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Plasma Fractionation Market

  • 18. 5. France Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Plasma Fractionation Market

  • 19. 9. Italy Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Plasma Fractionation Market

  • 20.13. Spain Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Plasma Fractionation Market

  • 21.1. Eastern Europe Plasma Fractionation Market Overview
  • 21.2. Eastern Europe Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Plasma Fractionation Market

  • 22.1. Russia Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Plasma Fractionation Market

  • 23.1. North America Plasma Fractionation Market Overview
  • 23.2. North America Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Plasma Fractionation Market

  • 24.1. USA Plasma Fractionation Market Overview
  • 24.2. USA Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Plasma Fractionation Market

  • 25.1. Canada Plasma Fractionation Market Overview
  • 25.2. Canada Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Plasma Fractionation Market

  • 26.1. South America Plasma Fractionation Market Overview
  • 26.2. South America Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Plasma Fractionation Market

  • 27.1. Brazil Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Plasma Fractionation Market

  • 28.1. Middle East Plasma Fractionation Market Overview
  • 28.2. Middle East Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Plasma Fractionation Market

  • 29.1. Africa Plasma Fractionation Market Overview
  • 29.2. Africa Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Plasma Fractionation Market Competitive Landscape And Company Profiles

  • 30.1. Plasma Fractionation Market Competitive Landscape
  • 30.2. Plasma Fractionation Market Company Profiles
    • 30.2.1. Baxter International Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Bio Products Laboratory Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Biotest AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. CSL Limited
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. Grifols S. A
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Plasma Fractionation Market Competitive Benchmarking

32. Global Plasma Fractionation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Plasma Fractionation Market

34. Plasma Fractionation Market Future Outlook and Potential Analysis

  • 34.1 Plasma Fractionation Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Plasma Fractionation Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Plasma Fractionation Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer